| Particulars (Rupees in Crores.) | Sept-2024 | Jun-2024 | Mar-2024 | Dec-2023 | Sept-2023 |
|---|---|---|---|---|---|
Gross Sales | 147.35 | 115.72 | 136.46 | 150.5 | 143.02 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 147.35 | 115.72 | 136.46 | 150.5 | 143.02 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 7.42 | 6.54 | 13.55 | 8.46 | 6 |
Total Income | 154.77 | 122.26 | 150.01 | 158.96 | 149.02 |
Total Expenditure | 140.35 | 129.71 | 142.5 | 150.65 | 146.58 |
PBIDT | 14.42 | -7.45 | 7.51 | 8.31 | 2.44 |
Interest | 0.98 | 0.87 | 0.82 | 0.85 | 0.91 |
PBDT | 13.44 | -8.32 | 6.69 | 7.46 | 1.53 |
Depreciation | 8.68 | 8.73 | 8.81 | 9.11 | 9.31 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 0 | 0 | 0.07 | 0.62 | 0 |
Deferred Tax | 0.05 | -1.17 | -0.2 | -0.07 | 0.51 |
Reported Profit After Tax | 4.71 | -15.88 | -1.99 | -2.2 | -8.29 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 4.71 | -15.88 | -1.99 | -2.2 | -8.29 |
Extra-ordinary Items | 2.74 | 2.74 | 2.67 | 2.16 | 2.59 |
Adjusted Profit After Extra-ordinary item | 1.97 | -18.62 | -4.66 | -4.36 | -10.88 |
EPS (Unit Curr.) | 0.77 | -2.59 | -0.23 | -0.37 | -1.35 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 9.78 | -6.43 | 5.5 | 5.52 | 1.7 |
PBDTM(%) | 9.12 | -7.18 | 4.9 | 4.95 | 1.06 |
PATM(%) | 3.19 | -13.72 | -1.45 | -1.46 | -5.79 |
Panacea Biotec's stock has seen a 37% gain over the past six months. Panacea Biotec's stock has gained a total of 76% in the last one year.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
